Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 93Breast Neoplasms 79Lung Neoplasms 50Prostatic Neoplasms 45Colorectal Neoplasms 33Carcinoma, Non-Small-Cell Lung 31Pancreatic Neoplasms 29Hematologic Neoplasms 22Lymphoma 19Brain Neoplasms 19Stomach Neoplasms 17Ovarian Neoplasms 17Urinary Bladder Neoplasms 15Multiple Myeloma 14Melanoma 14Liver Neoplasms 14Leukemia, Myeloid, Acute 14Head and Neck Neoplasms 13Esophageal Neoplasms 13Carcinoma, Hepatocellular 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Leukemia 12Disease 12Carcinoma, Renal Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 11Kidney Neoplasms 11Colonic Neoplasms 11Glioma 10

Interventions

Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Postural Orthostatic Tachycardia Syndrome × 30 days × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡